FAKULTN THOMAYEROVA NEMOCNICE
A United Kingdom buyer, with 13 published contracts, worth £2.1bn, most recently 6 months ago.
Top 5 suppliers won 90% of awarded value — £1.4bn of £1.5bn across 12 awards.
This public procurement contract involves the ongoing supply of the medicinal product containing the active substance nirsevimab (ATC J06BD08). The specific products required include: - LL-nirsevimab, 50MG injection solution, packaged as 1x0.5ML + 2 syringes - LL-nirsevimab, 100MG injection solution
This public procurement contract involves the ongoing supply of a medicinal product containing the active substance nusinersen (ATC M09AX07). The specific product is LL-nusinersen, in the form of a 2MG injection solution packaged as 1X5ML. The total quantity required is 200 units. This contract is i
This public procurement contract involves the supply of new medical devices, specifically a 'Therapeutic X-ray irradiator.' The intended outcome is to enhance healthcare services by providing advanced radiation therapy equipment. The contract is valued at approximately 10,495,000 CZK and is issued b
This public procurement contract involves the ongoing supply of a medicinal product containing the active ingredient risdiplam (ATC M09AX10). The required formulation is 0.75MG/ML in powder for solution, with a unit measure of 1+AD+5XSTŘ, totaling a quantity of 2,400 units. The contract is valued at
This public procurement contract involves the ongoing supply of the medicinal product containing the active substance aflibercept (ATC S01LA05). The contract specifies the delivery of two forms of aflibercept: 1) 40MG/ML injection solution in 1X0.1ML and 1X0.09ML units, with a total quantity of 7,50
This public procurement contract involves the ongoing supply of the medication containing the active ingredient fingolimod (ATC L04AE01). The specific product required is fingolimod in a dosage form of 0.5MG capsules, packaged in units of 28 capsules per box, with a total quantity of 3,300 boxes nee
